Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betahistine for Weight Loss in Obese Women
NCT00748436Phase 2Completed
- Sponsor
- Obecure Ltd.
- Start
- Sep 2008
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of betahistine in obesity (3 arms), sponsored by Obecure Ltd. Primary endpoints: Change in body weight at 12 weeks and Proportion of subjects achieving > 2.5% and/or >5.0 % weight loss at 12 weeks. Started Sep 2008; status: completed.
02
Drugs
betahistine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00748436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00748436.